Crescendo Biologics
Phase 2Crescendo Biologics is focused on novel T cell enhancingtherapeutics in immuno-oncology.
Founded
2008
Focus
Biologics
About
Crescendo Biologics is focused on novel T cell enhancingtherapeutics in immuno-oncology.
Funding History
2Total raised: $57M
Series B$32MAndera PartnersMar 15, 2021
Series A$25MAndera PartnersOct 15, 2018
Company Info
TypePrivate
Founded2008
LocationCambridge, United Kingdom
StagePhase 2
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile